Core Viewpoint - Danone's stock price increased by 4.09% to $17.06 on February 12, 2026, with trading volume surging to $13.33 million, outperforming the broader market and the packaged food sector [1] Recent Events - On February 5, 2026, the Austrian food safety authority announced a recall of certain batches of Aptamil and Milupa infant formula; on February 6, Danone recalled some infant formula in the Netherlands [2] - On February 11, 2026, the French Ministry of Health reported three infant deaths linked to problematic formula, prompting an investigation, although Danone clarified that its official imported formula did not use the implicated supplier ARA's ingredients [2] Institutional Perspectives - Huatai Securities noted on February 12, 2026, that the food and beverage sector's peak season remains strong, suggesting a focus on quality leading companies with improving fundamentals, indirectly boosting market sentiment for multinational food companies like Danone [3] - The European stock market shows a divergence, with the food sector demonstrating defensive characteristics, leading to a shift of funds towards stable assets [3]

Core Viewpoint - The Austrian food safety authority announced the recall of certain batches of infant formula from Danone due to updated regulations on Bacillus cereus toxin levels by the EU, affecting over 90 batches of products [1] Group 1: Company Actions - Danone has coordinated with Austrian authorities to recall specific batches of its Aptamil and Milupa infant formula brands [1] - The recall also extends to related batches sold in Germany, as these products may have crossed the border into Austria [1] Group 2: Regulatory Context - The recall is a response to recent updates in EU regulations regarding the permissible levels of Bacillus cereus toxins in food products [1] - The action reflects the company's compliance with food safety standards set by the European Union [1]